Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $435.07 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $146.85 | 1 | $0 (2017) |
| Merz Pharmaceuticals, LLC | $67.45 | 2 | $0 (2024) |
| ABBVIE INC. | $52.93 | 3 | $0 (2024) |
| Depomed, Inc. | $29.67 | 2 | $0 (2017) |
| GENZYME CORPORATION | $23.96 | 2 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $19.95 | 1 | $0 (2017) |
| Medtronic USA, Inc. | $18.55 | 1 | $0 (2019) |
| SI-BONE, Inc. | $15.17 | 1 | $0 (2018) |
| Genentech USA, Inc. | $12.90 | 1 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $12.63 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.01 | 3 | ABBVIE INC. ($36.31) |
| 2023 | $16.62 | 1 | AbbVie Inc. ($16.62) |
| 2021 | $44.75 | 1 | Merz Pharmaceuticals, LLC ($44.75) |
| 2019 | $43.74 | 3 | Medtronic USA, Inc. ($18.55) |
| 2018 | $50.82 | 4 | GENZYME CORPORATION ($23.96) |
| 2017 | $220.13 | 6 | Allergan Inc. ($146.85) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/07/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Musculoskeletal | ||||||
| 03/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/31/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/22/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $44.75 | General |
| Category: Musculoskeletal | ||||||
| 10/22/2019 | Medtronic USA, Inc. | SYNCHROMED (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Drug Infusion Systems | ||||||
| 10/10/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Sleep | ||||||
| 03/22/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $12.56 | General |
| Category: Musculoskeletal | ||||||
| 12/13/2018 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | Cash or cash equivalent | $15.17 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 12/04/2018 | GENZYME CORPORATION | LUMIZYME (Drug), POMPE - DISEASE | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 11/14/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Pain Management | ||||||
| 03/20/2018 | GENZYME CORPORATION | LUMIZYME (Drug), POMPE - DISEASE | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 10/18/2017 | Ipsen Biopharmaceuticals, Inc | Dysport 300 U-1 (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Neurology | ||||||
| 09/14/2017 | Allergan Inc. | BOTOX NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $146.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2017 | Depomed, Inc. | Nucynta (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Pain | ||||||
| 05/17/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $12.90 | General |
| 03/28/2017 | SANOFI-AVENTIS U.S. LLC | LANTUS (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: DIABETES | ||||||
| 02/23/2017 | Depomed, Inc. | Nucynta (Drug), Gralise | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 435 | 548 | $150,938 | $47,386 |
| 2022 | 13 | 608 | 790 | $225,380 | $71,871 |
| 2021 | 14 | 653 | 892 | $258,305 | $84,693 |
| 2020 | 15 | 618 | 828 | $233,482 | $71,072 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 118 | $27,376 | $10,737 | 39.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 84 | 105 | $28,560 | $7,751 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 43 | $12,986 | $5,971 | 46.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $12,393 | $4,622 | 37.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 37 | 37 | $22,385 | $4,447 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 58 | $9,860 | $3,936 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $12,410 | $3,935 | 31.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 27 | 27 | $12,231 | $2,540 | 20.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,214 | $2,269 | 36.5% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 15 | 15 | $5,595 | $1,129 | 20.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 58 | $928.00 | $48.61 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 182 | $42,224 | $15,785 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 102 | $30,804 | $13,679 | 44.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 108 | 144 | $39,168 | $11,055 | 28.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 39 | 39 | $17,901 | $6,038 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $15,330 | $5,056 | 33.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 40 | 40 | $24,200 | $5,055 | 20.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 43 | 44 | $19,932 | $4,411 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 66 | $11,220 | $4,254 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $8,126 | $2,916 | 35.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $8,085 | $1,786 | 22.1% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 14 | 14 | $5,222 | $1,231 | 23.6% |
| 76882 | Limited ultrasound scan of joint or other extremity structure lacking blood vessels | Office | 2022 | 13 | 14 | $2,240 | $553.34 | 24.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 58 | $928.00 | $52.92 | 5.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 189 | $43,848 | $17,341 | 39.5% |
About Dr. Paul Brockman, M.D
Dr. Paul Brockman, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902864465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Brockman, M.D has received a total of $435.07 in payments from pharmaceutical and medical device companies, with $59.01 received in 2024. These payments were reported across 18 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($435.07).
As a Medicare-enrolled provider, Brockman has provided services to 2,314 Medicare beneficiaries, totaling 3,058 services with total Medicare billing of $275,022. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Wyomissing, PA
- Active Since 05/03/2006
- Last Updated 03/25/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1902864465
Products in Payments
- BOTOX NEURO REHAB (Drug) $146.85
- Xeomin (Biological) $67.45
- BOTOX (Biological) $52.93
- Nucynta (Drug) $29.67
- LUMIZYME (Drug) $23.96
- Dysport 300 U-1 (Drug) $19.95
- SYNCHROMED (Device) $18.55
- iFuse Implant (Device) $15.17
- Horizant (Drug) $12.63
- Zilretta (Drug) $12.56
- Morphabond ER (Drug) $11.69
- LANTUS (Drug) $10.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Wyomissing
Haiping Mei, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,696
Li-Hong Lu, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,263
Kelley Crozier, Md, MD
Physical Medicine & Rehabilitation — Payments: $730.41
Sanghoon Kim, Md, MD
Physical Medicine & Rehabilitation — Payments: $588.08
Somkiat Hemtasilpa, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $428.76
Mary Elmer
Physical Medicine & Rehabilitation — Payments: $215.26